Noninflammatory comedones have greater diversity in microbiome and are more prone to biofilm formation than inflammatory lesions of acne vulgarisINTERNATIONAL JOURNAL OF DERMATOLOGYIF3.22020-12-087OAAI
A unique telomere DNA expansion phenotype in human retinal rod photoreceptors associated with aging and diseaseBRAIN PATHOLOGYIF6.22018-05-236OAAI
Reply to Contradictory Results with High-Dosage Rifamycin in Mice and HumansANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52013-02-015OAAI
Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of TuberculosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52012-08-01138OAAI
Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient MiceAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42011-05-0137OAAI
Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of TuberculosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52009-10-0190OAAI
Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42008-11-0164OAAI
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52008-04-01185OAAI
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52006-08-01127OAAI
Potent twice-weekly rifapentine-containing regimens in murine tuberculosisAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42006-07-0185OAAI
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse modelAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42005-12-0174OAAI
Weekly moxifloxacin and rifapentine is more active than the Denver regimen in murine tuberculosisAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42005-12-0151OA
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52005-06-01219OAAI
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis含莫西沙星的持续时间减少的方案可在鼠结核病中稳定治愈AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42004-11-15200PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向